shift at C-3' and a 3.2-ppm down field shift at C-2', which are consistent with the P and y shifts of the olefinic carbons caused by glycosylation at the allylic position4). Therefore the site of glucosidic linkage was determined as C-7', and the structure of compound C-I was shown to be 7'-0-/?-dglucopyranosylvalidoxylamine A (9).
The 13C NMRspectra of compounds C-II and C-III displayed a 10.2-ppm down field shift for C-2 md a 10.9-ppm down field shift for C-4, respectively.
Fherefore the sites of the glycosylation in compounds C-II and C-III were determined at C-2 and C-4, respectively, and the structures of compounds In the 13C NMR spectrum of compound C-IV, glucoside formation produced a 10.5-ppm down field shift for the allylie methine carbon (C-4'), and a 2.0-ppm up field shift and a 2.2-ppm down field shift for the olefinic carbons (C-3' and C-2', respectively). These shifts are in good agreement with the results previously reported for trestatin Table 1 . *H NMRdata of all eight possible mono-/?-D-glucosides of validoxylamine A (S in ppm, 7 in Hz). 2 4 Proton (Compound C-II) 3a (Compound C-III) 5a 1-H 3.592 (m) 3.374 (br s) 3.287 (br q) 3.289 (br s) 2-H 3.700 (dd, 7=9.5, 4.4) 3.797 (dd, 7-9.5, 4.0) 3.633 (dd, /=9.5, 4.0) 3.594 (dd, 7= 10.3, 4. A5). From these results, the structure of compound C-IV was shown to be 4'-0-/?-D-glucopyranosylvalidoxylamine A (6). Semi-synthesis of 7-O-^-D-Glucopyranosylvalidoxylamine A (5a) and
The preparation of 7-0-/?-D-glucopyranosylvalidamine (10), the pseudo-disaccharide unit of 5a whose decaacetate has been synthesized by Ogawa et al.6\ was carried out by microbial glycosylation of validamine with Rhodotorula lactosa. DEC. 1991 Scheme 3.
The reaction mixture (100ml) containing validamine (1 g), cellobiose (10 g) and the cell suspension of R. lactosa was incubated at 37°C for 48 hours with shaking. By this microbial glycosylation reaction, 10 (105 mg), 2-(9-/?-D-glucopyranosylvalidamine and 4-0-/?-D-grucopyranosylvalidamine mixture (520 mg) were obtained. The oxidative deamination of the primary amine of 10 was achieved by treatment with 3,5-di-ter£-butyl-l,2-benzoquinone7) under a stream of nitrogen. The coupling of the ketone derivative and valienamine by reductive alkylation with NaBH3CN gave a mixture of 5a and its epimer (5b) as illustrated in Scheme 1. The stereochemistry at the C-l position of 5a was determined by 1H NMR spectrum S 3.594 (dd, J1 2=4.0Hz, /2 3=10.3Hz, 2-H) as shown in Table 1 .
Similarly, 6-0-/?-D-glucopyranosylvalienamine (ll), the pseudo-disaccharide unit of 8a, was prepared by microbial glycosylation of valienamine with R. lactosa, which has recently been reported by Furumoto etal*\ The preparation of 8a was carried out by the coupling of ll with (2i?)-(2,4/3,5)-2,3,4-trihydroxy-5-hydroxymethylcyclohexanone7) (12) in a similar manner of that described for the preparation of 5a and then chromatographic separation (Scheme 2). The stereochemistry at the C-l position of 8a was determined by *H NMR spectrum S 3.510 (dd, /1 2=4.0Hz, /2>3=10.0Hz, 2-H) as shown in Table 1 .
Synthesis of ,5-di-ter/-butyll ,2-benzoquinone, and coupling of the resulting ketone derivative and valienamine by reductive alkylation with NaBH3CN gave a mixture of 3a and its 1-epimer (3b) . Both epimers were separated by column chromatography. The stereochemistry at the C-l position of 3a was determined by *H NMRspectrum S 3.797 (dd, /1 2=4.0Hz, /2 3=9.5Hz, 2-H) as shown in Table 1 . condensation reaction of the 5,6-diol (17) with the halide. The condensation of 17 with acetobromoglucose in the presence of AgOTfand TMUin dry dichloromethane at room temperature for 48hours gave a mixture of products. The resulting two j5-D-glucosides were inseparable by column chromatography on silica gel. Removal of the protecting groups, followed by chromatographic separation, gave 5-O-/^D-glucopyranosylvalienamine (18) and 6-0-jS-D-glucopyranosylvalienamine with the ratio of 4 : 1. Coupling of 18 and 12 by reductive alkylation with NaBH3CNgave a mixture of 7a and its 1-epimer DEC. 1991 (7b). Both epimers were separated by column chromatography. The stereochemistry at the C-l position of7a was determined by *H NMRspectrum S 3.577 (dd, /1 2=4.5Hz, /2 3=lO.OHz, 2-H) as shown in Table1. Experimental MP's were determined with a YamatoMP-21and are uncorrected. Optical rotations were measured with a Jasco DIP-370 digital polarimeter. *H NMRspectra and 13C NMRspectra were recorded with a Jeol JNM-GX400 spectrometer in deuterium oxide (D2O) containing sodium 3-(trimethylsilyl)propionate (TSP) as an internal standard. Mass spectra were recorded with a Jeol JMS-DX300 JMA-DA5000 spectrometer.
TLC was performed on HPTLC Silica gel 60 F254 (Merck) using solvent system I (PrOH-AcOH-H2O, 4: 1 :1) or II (BuOH-AcOH-H2O, 6:3: 1). HPLC analysis was performed on a YMCPA-5 column (4.6x 150mm) eluted at 3ml/minute flow rate with CH3CN-H2O(80:20) as a mobile phase and elution was followed by UVdetection at 210 nm.
Microbial /?-Glycosylation of Validamine R. lactosa IFO 1424 was cultured with shaking at 37°C for 48hours in a medium composed of 1% glucose, 0.3% (NH4)2SO4, 0.1% KH2PO4, 0.05% MgSO4-7H2O and 0.05% yeast extract (pH 5.7). The cells were collected by centrifugation at 10,000 x g for 15minutes, washed with 10mMphosphate buffer (pH 6.0). The washed cells (15 g, wet weight) were suspended in 50mMphosphate buffer (pH 6.0, 100ml). The cell suspensions containing 1 g ofvalidamine and 10 g of cellobiose were incubated at 37°C for 48 hours with shaking. The incubation mixture was centrifuged and the supernatant was applied to a column of Dowex 50W-X2(H+, 100ml) and eluted with 0.5n NH4OH.The concentrate was applied to a column of Dowex 1-X2 (OH~, 2. The glucoside mixture (520mg) and NaHCO3(500mg) were dissolved in water (5 ml), and a solution of benzyloxycarbonyl chloride (0.8 ml) in toluene (2.5 ml) was added dropwise to the solution under ice cooling, followed by stirring at the same temperature for 1 hour and then at room temperature for 3 hours. The reaction mixture was adjusted to pH 5 with 2n HC1and extracted with toluene. The water layer was applied to a column of Amberlite 
Microbial^-Glycosylation of Valienamine
The cell suspensions containing 1 g of valienamine and 10g of cellobiose were incubated at 37°C for 24hours with shaking. The incubation mixture was treated in a similar manner of that described for transglucosylation of validamine. The transglucosylation products were purified on a column of Dowex 1-X2 (OH~, 2.5 x 90cm) and eluted with water to give 7-0-/?-D-glucopyranosylvalienamine (130mg), 6-0-^D-glucopyranoyslvalienamine (ll, 190mg) and 4-0-/?-D-glucopyranosylvalienamine (60mg) in order of elution from the column. Physico-chemical properties and NMR data of these compounds are shown in the literature8).
7-O-/?-D-Glucopyranosylvalidoxylamine
A (5a) 10 (lOOmg) and 3,5-di-ter/-butyl-l,2-benzoquinone (95mg) were dissolved in MeOH (5ml), and the solution was stirred under a stream of nitrogen at roomtemperature for 24hours. After adding water (1 ml), the reaction mixture was adjusted to pH 1.2 with 2n H2SO4and stirred at room temperature for 3 hours. After adding water (25ml), the reaction mixture was washed five times with chloroform. The water layer is adjusted to pH 5.5 with Dowex1-X2 (OH") resin. The reaction mixture was filtered and concentrated under reduced pressure. The residue (45mg) and valienamine (60mg) were dissolved in DMF(3ml), and 2n HC1 (0.12ml) and NaBH3CN (150mg) were added to the solution, followed by stirring at 37°C for 17hours. The reaction mixture was concentrated under reduced pressure, and the residue was dissolved in water (10ml) and chromatographed on a column of Dowex 50W-X2(H+, 10ml). The column was washed with water and eluted with 0.5n NH4OH.The eluate was concentrated and applied to a column of Amberlite CG-50 (NH4+, 8 ml). The effluent and washings were concentrated and then applied to.a column of Dowex1-X2 (OH", 1 x35cm). The column was eluted with water to 
ll (60 mg) and (2JR)-(2,4/3,5)-trihydroxy-5-hydroxymethylcyclohexanone7) (12, 100 mg) were dissolved in DMF(3ml), and 2n HC1 (0.12ml) and NaBH3CN(150mg) were added to the solution, followed by stirring at 27°C for 24hours. The reaction mixture was treated in a similar mannerto that described for the preparation of 5a. A mixture of coupling products was finally applied to a column of Dowex1-X2 3-O-jg-D-Glucopyranosylvalidoxylamme A (3a) A suspension of 4,7-0-benzylidene-Af-(benzyloxycarbonyl)validamine12) (13, 4.8 g) and 7V-acetylimidazole (4.0g) in DMSO(45ml) and pyridine (5ml) was stirred for 48hours at room temperature. DEC. 1991 The resulting solution was concentrated under reduced pressure and the residual syrup was dissolved in EtOAc. The solution was washed with 2n HC1 and saturated aqueous NaHCO3, and dried over MgS04. The filtrate was concentrated and chromatographed on a column of silica gel (200ml) eluted with hexane -EtOAc (1 : 1) to give To a stirred solution of 14 (660mg) in dry CH2C12 (5 ml) were added AgOTf (670mg), TMU(0.7ml) and molecular sieves 4A (1 g), and then acetobromoglucose (1.2 g) was added to the mixture. The reaction mixture was stirred at room temperature for 16hours, diluted with CH2C12 (15ml) and filtered through Celite. The filtrate was concentrated and the residue dissolved in a mixture of coned NH4OH-MeOH (1 : 4, 40 ml), followed by stirring overnight at room temperature. The reaction mixture was concentrated and the residue was dissolved in MeOH(33ml). To the solution was added 0.5n HC1(10ml), followed by stirring under reflux for 30minutes. The reaction mixture was cooled to room temperature, adjusted to pH 5.0 with saturated aqueous NaHCO3and concentrated under reduced pressure. The residue was dissolved in water, applied to a column of Amberlite XAD-4(20ml) and eluted with MeOH.The eluate was concentrated and then applied to a column of Toyopearl HW-40S(2.2 x 115cm). The column was eluted with 20% MeOHto give 3-O-^D-glucopyranosyl-7V-(benzyloxycarbonyl)validamine (15, 380 mg). 15: Rf0.53 (System II); [a] £5 +22.7°(c 1, H2O); 13C NMR (D2O) S 31.2 (t, C-6), 41.3 (d, C-5), 53.7 
